| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |